about
State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectivenessThe disconnect between China's public health and public security responses to injection drug use, and the consequences for human rightsHealth and human rights concerns of drug users in detention in Guangxi Province, ChinaPhylogeographic analyses reveal a crucial role of Xinjiang in HIV-1 CRF07_BC and HCV 3a transmissions in AsiaComparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionHCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in ChinaControlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and ChinaExploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, ChinaLong-term effects of methadone maintenance treatment with different psychosocial intervention modelsBarriers and Potential Improvements for Needle and Syringe Exchange Programs (NSPs) in China: A Qualitative Study from Perspectives of Both Health and Public Security SectorsIllicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, ChinaGenotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central ChinaA Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USAEstimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking routeHIV/AIDS knowledge in detention in Hunan province, China.Structural-level factors affecting implementation of the methadone maintenance therapy program in China.Projecting dynamic trends for HIV/AIDS in a highly endemic area of China: estimation models for Liangshan Prefecture, Sichuan ProvinceThe Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China.HIV/AIDS behavioral interventions in China: a literature review and recommendation for future research.Correlates of methadone client retention: a prospective cohort study in Guizhou province, ChinaPeer-based behavioral health program for drug users in China: a pilot studyHIV/AIDS and drug use in China--interactions, impacts, and issues.Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.Scaling up the national methadone maintenance treatment program in China: achievements and challengesEvolution of information-driven HIV/AIDS policies in China.Who uses methadone services in China? Monitoring the world's largest methadone programme.HIV epidemic among drug users in China: 1995-2011Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three modelsA qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China.Organizational policy recommendations for control of STI/HIV among female sex workers in China: regular examination of workers in social hygiene clinics.Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users.Motivational profiles of clients seeking methadone maintenance therapy in China.Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.Yulu Shequ - a unique rehabilitation program for illicit drug users in Kaiyuan in southwest China.Concurrent heroin use among methadone maintenance clients in China.Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, ChinaEffects of a recovery management intervention on Chinese heroin users' community recovery through the mediation effect of enhanced service utilization.
P2860
Q28255620-1A4FA0C1-F449-4EE7-B19C-2557A384A9DFQ28474301-BDE98AA2-A19D-4FEF-82EA-680DBC8DFF3BQ28474306-47948E89-06F9-4840-AE61-693EB8CECE28Q28476536-8CE918C1-486E-438A-8083-F0F410D1AB35Q28476802-66256571-1A2B-4C33-AE54-2C94D3F7A914Q28477079-10E9F987-D621-4FF0-BE0F-425C78E69DA0Q28482694-699578FF-D449-468C-A047-9E747413B718Q28539429-A27FE604-6EEC-4834-A5B9-11B8A25695B8Q28539468-5ACAE2CC-7F5A-4446-B9E5-CA899D4887A1Q28545843-13A7F206-CDFA-44BE-8CDD-D3C1AADA7490Q28546679-AA3081E3-C17E-484E-B7C5-BADEF86E6750Q28547657-AB5D401C-9133-4CC3-8A32-4A4BACE7CD79Q33447050-D56D6F72-306C-4317-B67E-FBA02EE0F8C8Q33550575-7C2067CE-6117-45AB-B6A1-DCC17CA4E20CQ33567264-521B2466-3E14-4202-8058-3B4E2A12A0B9Q33624370-55ED80D3-A9A7-43A7-9D6B-01F0A1E5EEABQ33720890-263FC4C5-4AF3-416B-A037-826ADCB70389Q33761624-BBFE786F-E058-421F-B88A-7E2F3BA42106Q33777337-5F4FDC1E-F8AC-469C-9EC5-6C62D7C61003Q33957246-C286E16A-B546-4AE4-B03D-930326C46FCAQ33991916-A1A25A5D-B75C-46F0-943D-FF6F3AB7AD90Q34013283-EE162808-056B-4E22-A817-B85C746C188FQ34119447-9C368141-1997-4DFC-A932-239732E23A88Q34167524-02461ADC-5D53-4495-BCE8-70DB320BE3B2Q34297996-07EBBD68-D88D-4B64-9E0D-8D18F43D1064Q34354301-AD968E82-B3BF-4826-BB90-1741F987A4FFQ34354349-BBD2DBA1-B7F5-4F9E-A1BF-F858D0D65224Q34455253-DC01EF1F-3DF6-4D42-A0C1-CEBF151E13F6Q34768591-03F813C4-9C69-4553-B62E-9EE293E15EBCQ34792063-3B518184-A55D-4B2D-8C4D-31C683E4D2A4Q34929981-50183EA7-DB09-4B09-A424-95D4D44D5ACCQ35048123-DE717E8F-653F-440D-81A7-B687475EB81EQ35051597-B880FC3B-9504-42F0-872D-F225241D30E4Q35129490-B30232E1-27E1-49EB-9E2D-1035EBBBD88BQ35211237-EC7FD960-6E6C-4384-A251-393112A2D90FQ35216327-A3C85450-7058-4B06-8093-CC50287AF647Q35373438-D0C27DA4-C86C-4C23-9435-31EE5B61EA01Q35672716-5EF61573-60EC-4780-B099-A9DD97CE62ADQ35814376-FAFA24F7-E9F6-4D5A-8D1C-FCB8B2BB4C4CQ36002799-8335E1B6-914F-4585-BB89-6432F6BB675C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rapid scale up of harm reduction in China.
@en
type
label
Rapid scale up of harm reduction in China.
@en
prefLabel
Rapid scale up of harm reduction in China.
@en
P1476
Rapid scale up of harm reduction in China.
@en
P2093
P304
P356
10.1016/J.DRUGPO.2006.11.014
P577
2007-02-14T00:00:00Z